Hyperkalemia Associated with Rapid Infusion of Conventional and Lipid Complex Formulations of Amphotericin B
Author:
- 8 July 1998
- journal article
- case report
- Published by Wiley in Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
- Vol. 18 (4) , 874-876
Abstract
A child developed hyperkalemia and cardiac arrest with infusion of an amphotericin B lipid complex 5.0 mg/kg over 1 hour. Another child, with chronic renal failure, developed hyperkalemia after infusion of conventional amphotericin B deoxycholate 1.0 mg/kg over 2 hours. Rapid infusion of the agent causes hyperkalemia in dogs and humans that is exacerbated in the setting of renal failure. A lipid formulation of amphotericin B is commercially available, and no reports of hyperkalemia are associated with its administration.Keywords
This publication has 14 references indexed in Scilit:
- Controlled pilot study of rapid amphotericn B infusionsArchives of Disease in Childhood, 1997
- Ventricular arrhythmias with conventional and liposomal amphotericinThe Lancet, 1993
- Bradycardia after rapid intravenous infusion of amphotericin BThe Lancet, 1993
- Risk of ventricular dysrhythmias during 1-hour infusions of amphotericin B in patients with preserved renal functionAntimicrobial Agents and Chemotherapy, 1992
- Double-blind randomized study of the effect of infusion rates on toxicity of amphotericin BAntimicrobial Agents and Chemotherapy, 1992
- Cardiopulmonary Toxicity after Liposomal Amphotericin B InfusionAnnals of Internal Medicine, 1991
- Randomized, double-blind trial of 1- versus 4-hour amphotericin B infusion durationsAntimicrobial Agents and Chemotherapy, 1990
- Risk factors of ventricular fibrillation during rapid amphotericin B infusionAntimicrobial Agents and Chemotherapy, 1985
- The Release of Potassium Ions from Candida albicans in the Presence of Polyene AntibioticsJournal of General Microbiology, 1974
- Amphotericin B Therapy in an Anephric PatientAntimicrobial Agents and Chemotherapy, 1973